Soft Tissue Sarcoma Surgery

Introduction

If you or someone close to you has been diagnosed with a soft tissue sarcoma, the period between diagnosis and surgery can feel overwhelming. Soft tissue sarcomas are uncommon cancers, the words used to describe them are unfamiliar, and the treatment plan often involves several specialists working together. You may be wondering what the operation actually involves, whether your limb can be preserved, how long recovery takes, whether you will need radiation or chemotherapy in addition to surgery, and what life looks like afterwards.

This article is written for patients (and family members of patients) who already have a sarcoma diagnosis and are now preparing for, or recovering from, surgery. It explains what soft tissue sarcoma surgery is, why it is performed, the different surgical approaches used, what to expect during preparation, the operation itself, recovery, possible complications, and the broader treatment plan that often surrounds surgery. The aim is to help you walk into your consultations with a clearer understanding of the medical landscape, so that the conversation with your own surgical and oncology team is more productive.

What Is Soft Tissue Sarcoma Surgery?

Soft tissue sarcoma surgery is the operation done to remove a cancerous tumour that has grown in the body’s soft tissues. “Soft tissues” is a broad term covering the structures that connect, support, and surround other organs and bones — including muscles, fat, fibrous tissue, tendons, blood vessels, nerves, and the lining of joints. Sarcomas are a group of cancers that begin in these tissues. They are uncommon compared with cancers of the breast, lung, or bowel, but they can occur in almost any part of the body.

The central goal of the surgery is to remove the tumour completely, together with a thin layer of healthy tissue around it. This surrounding layer is called the “margin.” A margin that is free of cancer cells under the microscope is described as a “negative” or “clear” margin, and achieving one is the single most important technical objective of the operation. Clear margins reduce the chance that the cancer will come back in the same place (called local recurrence).

A second goal, almost as important, is to preserve as much function as possible. If the tumour is in an arm or a leg, this usually means keeping the limb and the muscles, nerves, and blood vessels needed to use it. If the tumour is in the abdomen or chest, it means protecting nearby organs and structures wherever this can be done safely. Modern sarcoma surgery is shaped by the constant balance between these two goals: removing enough tissue to control the cancer, and leaving enough tissue to live well afterwards.

Why Sarcomas Are Treated Differently from Other Cancers

Sarcomas behave differently from the more common “carcinoma” cancers, and they are treated by surgeons and oncologists who specialise in this group. There are more than fifty recognised subtypes of soft tissue sarcoma, including liposarcoma (arising in fat), leiomyosarcoma (smooth muscle), synovial sarcoma, undifferentiated pleomorphic sarcoma, myxofibrosarcoma, malignant peripheral nerve sheath tumour, and several others. The subtype, the tumour’s grade (how aggressive the cells look under the microscope), its size, and its depth all influence the surgical plan. Because of this variability, major sarcoma guidelines from the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO) recommend that care be coordinated through a specialised sarcoma centre with a multidisciplinary team.

Why Is Soft Tissue Sarcoma Surgery Performed?

Surgery is the cornerstone of treatment for most localised soft tissue sarcomas. It is the only treatment that can physically remove the tumour, and for many patients it offers the best chance of long-term disease control. Surgery may be performed for several connected reasons:

• To remove the tumour with clear margins — the primary aim in localised disease.
• To relieve symptoms — pain, pressure on nearby structures, bleeding, or interference with limb or organ function.
• To confirm and stage the diagnosis — the removed tissue is examined in detail by a pathologist, which often refines the diagnosis, identifies the exact subtype, and informs whether further treatment is needed.
• To treat isolated metastases — in selected patients with a small number of sarcoma deposits in the lungs (the most common site of spread), surgery to remove those deposits can play a role in the overall plan.

Surgery is usually planned for sarcomas that are localised to one area and can be removed safely. When a tumour is very large, close to critical nerves or blood vessels, or has unfavourable features on imaging, the team may recommend treatment before surgery to shrink the tumour or improve the margin that can be achieved. This is called neoadjuvant therapy and may involve radiation, chemotherapy, or both.

Who Is a Candidate for Surgery?

Whether surgery is the right next step is a decision made by a multidisciplinary sarcoma team. Typically, surgery is considered when:

• A core needle biopsy has confirmed the diagnosis of soft tissue sarcoma.
• Imaging shows that the tumour is localised, or that any spread is limited and potentially treatable.
• The tumour can be removed with an acceptable margin, with or without preceding treatment to shrink it.
• The patient is medically fit enough to undergo the planned operation and the anaesthetic.

Patients with very advanced disease — where the cancer has spread widely — may not benefit from major resection, and the team may instead focus on systemic treatment (chemotherapy, targeted therapy) and on managing symptoms. In some cases, surgery is still considered for symptom relief even when complete cure is not possible. These judgements are individual, and they sit firmly within the conversation between you and your oncology team.

Alternatives and Companion Treatments

Surgery rarely stands entirely alone in sarcoma care. Several other treatments may be used instead of, before, or after the operation, depending on the situation.

Radiation Therapy

Radiation uses high-energy beams to destroy cancer cells. For many extremity sarcomas, particularly larger or higher-grade tumours, current NCCN and ESMO guidelines describe radiation as a standard part of treatment, given either before surgery (neoadjuvant) or after surgery (adjuvant). Radiation before surgery uses a smaller dose and a smaller treatment area, but can lead to more wound healing problems. Radiation after surgery uses a larger dose and a wider area, but with more reliable wound healing. Your team will discuss which sequence fits your situation.

Chemotherapy

Chemotherapy uses drugs that travel through the bloodstream to attack cancer cells. Its role in soft tissue sarcoma is more selective than in many other cancers. It is often considered for certain high-grade tumours, larger deep tumours, specific subtypes (such as some Ewing-family sarcomas or rhabdomyosarcoma), and in advanced disease. Whether chemotherapy is recommended in your case depends on the subtype, grade, size, location, and your overall fitness.

Targeted Therapy and Newer Agents

Some sarcoma subtypes respond to targeted drugs that act on specific molecular features of the tumour — for example, certain gastrointestinal stromal tumours and some unusual vascular sarcomas. These options apply to a minority of patients and require detailed pathology to identify.

Active Surveillance for Selected Benign-Behaving Tumours

For some slow-growing or borderline tumours, a period of careful watching may be reasonable. This applies to a small subset of patients and not to typical soft tissue sarcomas, which usually need active treatment.

The point of describing these alternatives is not to suggest that any of them replaces surgery for most patients. Surgery remains central. But understanding how the other modalities fit around the operation helps make sense of the overall treatment plan.

Surgical Approaches

Soft tissue sarcoma surgery is not a single operation. The approach is chosen based on where the tumour is, how big it is, what structures it lies near, and how aggressive it appears on biopsy and imaging.

Wide Local Excision (Limb-Sparing Surgery)

This is the most common operation for sarcomas of the arms and legs. The surgeon removes the entire tumour along with a cuff of normal-looking tissue around it. Limb-sparing surgery is now the standard approach for most extremity sarcomas; sarcoma centres aim to achieve clear margins while preserving the limb. Often this is combined with radiation therapy before or after surgery to reduce the risk of local recurrence.

The exact amount of healthy tissue removed depends on the natural barriers around the tumour. A thick layer of muscle or a tough sheet of fascia can act as a margin even if it is thin. Conversely, when the tumour is up against a major nerve or blood vessel, the surgeon may carefully dissect that structure free if it is not directly invaded.

Retroperitoneal Sarcoma Surgery

Retroperitoneal sarcomas grow in the back of the abdomen, behind the lining that contains the bowel. They are often large by the time they are found because they have room to grow without causing early symptoms. Surgery here is complex. The tumour usually sits close to (or directly involves) the kidney, parts of the bowel, major blood vessels, the spleen, or the pancreas, and removing it sometimes means removing one or more of these neighbouring organs as part of the same operation. This is called an “en bloc” resection — taking the tumour and the structures attached to it as a single specimen, to give the best chance of clear margins.

Retroperitoneal sarcoma operations are usually performed in centres that specialise in this disease, because the planning, the surgical technique, and the post-operative care are all demanding.

Trunk, Chest Wall, and Head and Neck Resections

Sarcomas of the chest wall, abdominal wall, back, or head and neck require operations tailored to the anatomy. Chest wall sarcomas may involve removing a section of rib and replacing it with a mesh or graft. Head and neck sarcomas may involve close work with ear, nose, and throat surgeons or oral and maxillofacial surgeons, and reconstruction is often planned in the same operation.

Reconstruction

When a wide excision leaves a large defect, reconstructive surgery is done either at the same time or in a planned second stage. Options include:

• Skin grafts — thin layers of skin taken from another part of the body to cover the wound.
• Muscle and skin flaps — blocks of tissue with their own blood supply, moved into the defect to fill and cover it.
• Vascular reconstruction — if a major blood vessel is removed with the tumour, it can be rebuilt using a graft, either from your own veins or from synthetic material.
• Nerve grafts and tendon transfers — used in selected cases to restore movement or sensation.
• Bone reconstruction — when part of a bone has to be removed with the tumour, it can sometimes be replaced with a metal prosthesis or a bone graft.

A plastic or reconstructive surgeon is often part of the operating team for these cases.

Amputation

Amputation — removal of part of a limb — is now uncommon in sarcoma care, but it remains an option when limb preservation is not safe. This applies when the tumour involves the main nerves and blood vessels of the limb in a way that cannot be reconstructed, when previous surgery and radiation have already used the available options, or when keeping the limb would leave it painful and non-functional. When amputation is considered, it is always discussed in detail with the patient, including what level of amputation is needed, what prosthetic options exist afterwards, and what rehabilitation will involve. Specialised prosthetic care and rehabilitation can restore meaningful function after amputation, particularly with modern limb prostheses.

Metastasectomy

In selected patients with a small number of sarcoma deposits in the lungs and no other sites of disease, surgery to remove those deposits (metastasectomy) is sometimes part of the plan. The decision depends on the number, size, and behaviour of the deposits, the time since the original tumour, and the patient’s overall fitness.

Preparing for Surgery

The weeks before sarcoma surgery are used to confirm the diagnosis, plan the operation in detail, and make sure you are as fit as possible for the procedure.

Imaging and Biopsy

By the time you are scheduled for surgery, most of the following will usually have been done:

• MRI of the tumour area — the most detailed test for soft tissue, showing exactly which structures the tumour touches.
• CT scan of the chest — to look for any spread to the lungs, the most common site of sarcoma metastasis.
• CT of the abdomen and pelvis — for retroperitoneal and abdominal sarcomas.
• PET-CT — used in selected situations to look for spread.
• Core needle biopsy — a tissue sample taken with a needle, ideally planned by the team that will later operate, so that the biopsy track can be removed at the time of definitive surgery.

Multidisciplinary Planning

Sarcoma care is reviewed by a multidisciplinary team that typically includes a surgical oncologist (or an orthopaedic oncologist for limb tumours), a medical oncologist, a radiation oncologist, a pathologist, a radiologist, and reconstructive and rehabilitation specialists. The team reviews your scans and biopsy together and agrees on a plan. This kind of coordinated review is recommended by international sarcoma guidelines and is associated with better outcomes.

Pre-Operative Health Assessment

Before surgery, your fitness for the operation is checked. This usually includes blood tests, heart and lung assessment, a review of any other medical conditions (such as diabetes or heart disease), and a review of medications. Blood-thinning medications often need to be paused, and the timing is decided with your medical team. If you smoke, stopping before surgery improves wound healing and reduces lung complications — this matters particularly for sarcoma surgery, where wound healing is already a key concern, especially after radiation.

Practical Preparation

You will be told when to stop eating and drinking before surgery, what to bring to hospital, and whether you can take your usual medications on the morning of the operation. For larger operations, particularly those with significant reconstruction, it helps to arrange support at home for the first weeks after discharge. Walking aids, a temporary change of bedroom location, and help with daily tasks may all need to be planned in advance.

What Happens During Surgery

The details of the operation depend on the location and type of tumour, but the general pattern is similar.

Anaesthesia

Soft tissue sarcoma surgery is almost always done under general anaesthesia, meaning you are asleep for the operation. For limb operations, a regional anaesthetic (a nerve block) is often added to provide longer-lasting pain relief after surgery.

The Operation Itself

The surgeon makes a planned incision over the tumour, designed to allow safe removal of the tumour together with the biopsy track and any tissue affected by previous procedures. The tumour is carefully separated from surrounding structures while keeping its outer covering intact — cutting into the tumour during surgery can spread cancer cells and is avoided.

Once the tumour is removed, the surgeon checks the area and may take additional small samples from the edges of the cavity to confirm that no cancer cells have been left behind. If reconstruction is planned, it is done at this stage: a muscle flap is rotated into place, a skin graft is laid down, a blood vessel graft is sewn in, or a piece of mesh is fitted.

How Long Does the Surgery Take?

The duration depends greatly on the operation. A relatively superficial extremity tumour may be removed in around two hours. A large retroperitoneal sarcoma with removal of nearby organs, or an extremity resection with major reconstruction, can take six to eight hours or more.

Recovery and Healing

Hospital Stay

For most extremity sarcoma operations, hospital stay is around three to seven days, sometimes shorter for smaller tumours and longer if a complex reconstruction has been done. Retroperitoneal and abdominal sarcoma surgery usually requires a longer stay, often a week or more, because the bowel needs time to recover and because monitoring after major abdominal surgery is more intensive.

Pain Control

Pain is managed with a combination of medications, often starting with stronger pain relief given through a drip or by a patient-controlled pump and stepping down to tablets as you recover. Nerve blocks placed before surgery can give good pain control for the first day or two. Pain typically improves substantially within the first week.

Wound Care and Drains

Wound healing is followed closely, particularly if you have had radiation before surgery, which makes the tissue heal more slowly. Drains are usually removed once the fluid output drops to a low level, often within a few days to two weeks. You will be given specific instructions on how to keep the wound clean and dry, when to shower, and what signs of infection to watch for.

Mobility and Physiotherapy

Early movement is encouraged. After extremity surgery, a physiotherapist will start gentle movements and exercises within the first day or two when safe, gradually progressing as the wound heals. Rehabilitation can continue for many weeks after discharge. After abdominal surgery, getting out of bed and walking short distances early helps reduce the risk of pneumonia and blood clots.

The First Three Months

Most patients see meaningful improvement in pain, swelling, and strength over the first six to twelve weeks. Return to work depends on the kind of work you do and the kind of surgery you had — sedentary work may be possible within a few weeks; heavier work may need several months. Limb function continues to improve well beyond the three-month mark, especially with continued rehabilitation. Recovery after a major reconstruction or after combined surgery and radiation is slower, and patience is important.

Risks and Complications

All major surgery carries risks. Your surgical team will discuss the specific risks for your operation and your situation in detail during the consent process. In general, possible complications of soft tissue sarcoma surgery include:

• Wound healing problems — including delayed healing, breakdown of the wound, or fluid collection under the skin. This risk is higher when radiation has been given before surgery, when reconstruction is complex, or when nearby tissue has poor blood supply.
• Infection — in the wound or deeper in the tissues.
• Bleeding — usually controlled during the operation, but occasionally requiring further treatment.
• Blood clots — in the legs or lungs. Preventive measures (compression stockings, blood-thinning injections, early movement) are used routinely.
• Nerve injury — tumours that lie close to nerves can require those nerves to be removed or carefully dissected. This can lead to weakness, numbness, or pain in the area supplied by the nerve.
• Vascular injury — uncommon but possible, especially with tumours near major blood vessels.
• Bowel or organ injury — for abdominal and retroperitoneal operations.
• Loss of function in the limb or area operated on — even with successful limb-sparing surgery, some loss of strength, range of movement, or sensation is common.
• Lymphoedema — persistent swelling of a limb, particularly after operations near major lymph nodes.
• Local recurrence — the sarcoma can return in or near the original site. This risk is influenced by tumour grade, margin status, and whether radiation was used.
• Distant recurrence — sarcoma can come back in distant organs, most often the lungs, even after a complete local resection.

The chance of these complications varies widely depending on the tumour, the operation, and individual health factors. Care in a specialised sarcoma centre is associated with lower rates of positive margins and better long-term outcomes, which is one of the reasons international guidelines recommend referral to such centres whenever possible.

Adjuvant Treatment After Surgery

Once the operation is complete, the entire specimen is examined by a pathologist. The final report typically describes the exact subtype of sarcoma, the grade, the size, the depth, whether the margins are clear, and whether features such as necrosis (dead tissue) or vascular invasion are present. These details guide what happens next.

Radiation After Surgery

If radiation has not already been given before surgery, it may be recommended afterwards, particularly for higher-grade tumours, larger or deeper tumours, and when margins are very narrow. Radiation reduces the risk that the sarcoma will come back at the original site.

Chemotherapy

Chemotherapy after surgery is used selectively. It is considered more often for certain subtypes (for example, some childhood sarcomas, and some adult sarcomas with high-risk features) and is less routinely used in others. The decision is individual and is made by the medical oncology team in light of the full pathology report and your overall situation.

Re-Excision

If pathology shows that the margins are not clear, a second operation to remove additional tissue may be recommended. This is a normal part of sarcoma care and does not mean the original operation was unsuccessful — it reflects how closely margins are checked.

Life After Surgery

Life after sarcoma surgery includes both physical recovery and a longer phase of follow-up and surveillance.

Physical Function and Rehabilitation

Ongoing physiotherapy and, in some cases, occupational therapy can make a significant difference to function. Strength, range of movement, balance, and confidence in using the affected limb all improve with structured rehabilitation. For patients who have had amputation, prosthetic fitting and rehabilitation begin once the wound has healed, and many people return to a wide range of activities, including work and sports, with modern prostheses.

Follow-Up and Surveillance

After the initial recovery, follow-up visits are scheduled at regular intervals for several years. Major sarcoma guidelines describe a pattern of clinical examination and imaging every three to six months for the first two to three years, then less frequently for at least another two to seven years, depending on the tumour. Imaging usually includes the original tumour site (typically MRI or ultrasound for limb tumours, CT for abdominal tumours) and the chest (CT or chest X-ray) to monitor for any spread to the lungs.

Most recurrences happen within the first two to three years, which is why follow-up is most intense during that period. Recurrences detected early are more likely to be treatable.

Outlook

The long-term outlook after sarcoma surgery depends on several factors that the pathology report makes clear: the tumour’s subtype, its grade, its size, its depth, and whether clear margins were achieved. Lower-grade, smaller, completely resected tumours generally have a more favourable outlook than larger, higher-grade tumours. Because sarcomas are so varied, broad numbers can be misleading, and the most meaningful estimate of your own outlook will come from your oncology team, who can consider all of the factors specific to your case.

Emotional Recovery

Recovering from cancer surgery is also an emotional process. Many patients describe a complicated mixture of relief that the tumour has been removed, anxiety about recurrence, and the work of adjusting to changes in their body and capability. Speaking with a counsellor, joining a sarcoma support group, or connecting with other patients who have been through similar treatment can help. Mental and emotional support is a recognised part of cancer care and is not a sign of weakness.

Soft Tissue Sarcoma Surgery in Children

Soft tissue sarcomas can occur in children, although the subtypes seen in childhood are often different from those in adults. The most common paediatric soft tissue sarcoma is rhabdomyosarcoma, which arises from cells that would normally develop into muscle. Other sarcomas seen in children include some forms of synovial sarcoma, infantile fibrosarcoma, and a group sometimes called non-rhabdomyosarcoma soft tissue sarcomas.

Treatment of childhood sarcoma differs from adult care in several ways:

• It is highly multidisciplinary and centred on paediatric oncology. Children are treated by paediatric oncology teams that include paediatric surgeons, paediatric oncologists, radiation oncologists trained in treating children, and specialist nurses and therapists.
• Chemotherapy plays a larger role. Many childhood sarcomas are more chemosensitive than adult sarcomas. Treatment plans often combine chemotherapy with surgery and sometimes radiation, with the exact sequence guided by the diagnosis.
• Surgery is planned around growth and development. Surgeons consider not just the immediate result but how the child’s body will continue to grow afterwards, which affects choices about reconstruction and timing.
• Long-term follow-up extends well into adulthood. Children treated for sarcoma may have follow-up care for many years, watching for late effects of treatment as well as for recurrence.

For parents, the most important step is making sure the child is being cared for in a centre with experience in paediatric sarcoma. Outcomes for many childhood sarcomas have improved substantially over recent decades, and most children receive treatment as part of internationally coordinated protocols.

Frequently Asked Questions

Will I lose my arm or leg?

For most patients with sarcomas of the arms and legs, limb-sparing surgery is possible. Amputation is now uncommon and is generally considered only when the tumour involves critical structures in a way that cannot be reconstructed, or when keeping the limb would result in a painful, non-functional outcome. Whether your limb can be preserved depends on detailed imaging and a discussion with a sarcoma surgical team.

Why is a biopsy done before surgery? Could the tumour be removed in one operation?

Sarcomas are uncommon and behave very differently depending on the subtype. A biopsy confirms the diagnosis, identifies the subtype, and allows the team to plan the right operation with the right margin and the right additional treatments. Removing a tumour without a confirmed diagnosis risks an inadequate operation that may require further surgery and may worsen outcomes. Sarcoma guidelines strongly favour biopsy before definitive surgery, ideally planned by the team that will operate.

Do I need radiation or chemotherapy in addition to surgery?

That depends on the subtype, grade, size, depth, location, and margin status of the tumour, as well as your overall health. For many extremity sarcomas, radiation is part of the plan. Chemotherapy is used more selectively. Your medical oncologist and radiation oncologist will review the full pathology report and discuss with you what is recommended.

Will the cancer come back?

There is always some risk of recurrence after sarcoma surgery, and that risk varies depending on the tumour. Follow-up imaging and clinic visits over several years are designed to find any recurrence early, when it is more likely to be treatable. Most recurrences happen within the first two to three years after surgery.

How long until I can walk, drive, or return to work?

Walking begins early after most operations, often within the first day or two, although the distance and pace depend on the surgery. Driving usually resumes once you are off strong pain medication and can perform an emergency stop without pain or hesitation, which may be a few weeks. Return to work depends on the kind of work you do; office work may resume within a few weeks, while physically demanding work may take several months.

Should I get a second opinion?

Sarcoma is rare and complex, and several international guidelines recommend that patients be assessed at a specialised sarcoma centre before definitive treatment. A second opinion at a sarcoma centre is a reasonable step and is widely supported in current practice. Bringing your scans, biopsy slides, and pathology report makes the second opinion most useful.

Can sarcoma be treated without surgery?

For most localised sarcomas, surgery is the central treatment, and current guidelines describe it as the best chance of long-term control. Other treatments (radiation, chemotherapy, targeted therapy) usually work alongside surgery rather than replacing it. In situations where surgery is not possible or not appropriate — for example, very advanced disease or specific subtypes — non-surgical treatments may be the focus.

Conclusion

Soft tissue sarcoma surgery is a carefully planned operation with a clear aim: to remove the tumour completely with a margin of healthy tissue while preserving as much function as possible. The shape of the operation — limb-sparing excision, retroperitoneal resection, chest wall or head and neck surgery, reconstruction, or, in selected cases, amputation — depends on where the tumour is, what subtype it is, and how it relates to surrounding structures. Around the surgery sits a wider plan that may include radiation, chemotherapy, targeted therapy, rehabilitation, and years of follow-up.

Because sarcomas are uncommon and varied, international guidelines emphasise the value of being cared for by a multidisciplinary team with specific experience in sarcoma. The questions worth bringing to your team are the ones that matter most to your life: what is the goal of the operation in your particular case, what function can be preserved, what additional treatments are being recommended and why, and what the follow-up plan will look like. The information in this article is meant to make those conversations easier, not to replace them.